Clik here to view.
Clik here to view.
Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in...
CHENNAI, India A 16 years old boy from Chennai who was suffering from decompensated chronic liver disease due to ‘Cholesteryl ester storage disease’, has undergone successful liver transplant at...
View ArticleClik here to view.
Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the...
SAN DIEGO Apros Therapeutics, Inc., a drug discovery and development company focused on tissue-targeted Toll-Like Receptor 7 (TLR7) agonists for the treatment of cancer and infectious diseases,...
View ArticleClik here to view.
Vaxess Technologies to Develop Coronavirus + Influenza Combo Patch Vaccine in...
CAMBRIDGE, Mass. & TAIPEI, Taiwan Vaxess Technologies, an innovative biotechnology company developing the MIMIX smart release patch, has formed a partnership with Taiwanese pharmaceutical...
View ArticleClik here to view.
DKT WomanCare and Incepta Pharmaceuticals Ink Strategic Deal to Expand...
PARIS WomanCare Global Trading CIC (DKT WomanCare) and Incepta Pharmaceuticals, Ltd. signed a strategic agreement on July 1, 2020 to register, supply, promote and sell Medogen® in 40 countries...
View ArticleClik here to view.
EpimAb Biotherapeutics Announces FDA Clearance of its IND Application for...
SHANGHAI EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced that it has received “STUDY MAY PROCEED” letter from the U.S. Food and Drug...
View ArticleClik here to view.
Forma Therapeutics Appoints Two New Vice Presidents to Lead Key...
WATERTOWN, Mass. Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the appointments of...
View ArticleClik here to view.
Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion...
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the expansion of its cell therapy manufacturing capabilities with the opening of a new 24,000...
View ArticleClik here to view.
Croma Establishes New Joint Venture in China
LEOBENDORF, Austria Asia in general and China in particular represent the fastest growing aesthetic medicine markets worldwide. CNBG and Croma entered a far reaching, long-term cooperation combining...
View ArticleClik here to view.
Clik here to view.
Singapore and Apple Partner on National Health Initiative Using Apple Watch
CUPERTINO, Calif. The government of Singapore and Apple® today announced their partnership on the health initiative LumiHealth, a personalized program to encourage healthy activity and behaviors...
View ArticleClik here to view.
新たな研究：ハンドドライヤーによる手の乾燥はペーパータオルと同じくらい衛生的
米マサチューセッツ州イーストロングメドー （ビジネスワイヤ） — アリゾナ大学健康科学部の研究チームは、2年に及ぶ徹底的な過程を経た研究成果として「Comparison of electric hand dryers and paper towels for hand hygiene: a critical review of the...
View ArticleClik here to view.
Takeda to Divest TachoSil® to Corza Health for €350 Million
OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest its TachoSil® Fibrin Sealant Patch (“TachoSil®”) to...
View ArticleClik here to view.
UAE’s 20by2020 Initiative Brings Life-Changing Water Solution to Thousands in...
ABU DHABI, United Arab Emirates Thousands of people across three Cambodian villages can now live safer, healthier lives following the deployment of new water purifying technology as part of the...
View ArticleClik here to view.
NTTVC公布与NTT合作创建的5亿美元基金
加利福尼亚州帕洛阿尔托 (美国商业资讯)–NTTVC今天公开宣布了其5亿美元的基金，旨在通过利用合作伙伴关系力量帮助初创企业快速实现全球规模。该独立风险投资公司由创业者和投资人Vab Goel与全球技术服务提供商NTT合作创立。公司还宣布了对五家初创公司的投资，这些初创公司为企业和消费者提供具影响力的创新技术，五家公司分别是：Celona、Eko、nference、Shoreline和UDP...
View ArticleClik here to view.
NTTVC公布与NTT合作创建的5亿美元基金
加利福尼亚州帕洛阿尔托 (美国商业资讯)–NTTVC今天公开宣布了其5亿美元的基金，旨在通过利用合作伙伴关系力量帮助初创企业快速实现全球规模。该独立风险投资公司由创业者和投资人Vab Goel与全球技术服务提供商NTT合作创立。公司还宣布了对五家初创公司的投资，这些初创公司为企业和消费者提供具影响力的创新技术，五家公司分别是：Celona、Eko、nference、Shoreline和UDP...
View ArticleClik here to view.
Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and...
OSAKA, Japan & DURHAM, N.C. Santen Pharmaceutical Co., Ltd. (“Santen”) and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”) announced that Santen and Aerie have entered into an exclusive...
View ArticleClik here to view.
Clik here to view.
Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to...
SAN FRANCISCO & NEW YORK CITY & MELBOURNE Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the...
View ArticleClik here to view.
联拓生物宣布完成3.1亿美元的交叉轮融资
上海和普林斯顿（新泽西州） 家专注于为中国和亚洲主要市场的患者带来颠覆性药物的中国公司今日宣布，在其创立并获得Perceptive Advisors初始融资后，再次成功募集了3.1亿美元超额认购的交叉轮融资。 该轮融资由美国生物医药投资领域知名投资机构RA Capital和Venrock Healthcare Capital...
View Article